80332 Antidepressants class 1 or 2
Also known as: antidepressant screen, tricyclic antidepressant test
Drug screen, antidepressants class, one or two agents. Detects first or second generation antidepressant medications including tricyclics and monoamine oxidase inhibitors.
In Plain Language
mood medicine test
Clinical Context
Used in therapeutic drug monitoring, overdose evaluation, and substance abuse screening. Important in psychiatry and emergency medicine.
RVU Information
CPT 80332 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 80332?
CPT 80332 (Antidepressants class 1 or 2) is a Pathology & Lab code. Drug screen, antidepressants class, one or two agents. Detects first or second generation antidepressant medications including tricyclics and monoamine oxidase inhibitors.
Who uses CPT code 80332?
CPT 80332 is used by Toxicology, Psychiatry, Laboratory Medicine. Used in therapeutic drug monitoring, overdose evaluation, and substance abuse screening. Important in psychiatry and emergency medicine.
When is CPT 80332 used?
Used in therapeutic drug monitoring, overdose evaluation, and substance abuse screening. Important in psychiatry and emergency medicine.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.